MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
Director, Case CCC
Impact of Genomics on Cancer Diagnosis and Treatment
The Open Drug Policy Forum that we are planning for June 10 could not be more timely, with the topic of precision medicine receiving prominent attention. It will be the focus of a discussion at the Association of American Cancer Institutes (AACI) annual meeting in September, and was also featured in Sunday's New York Times. This article discussed the efforts being made by cancer centers to perfect their ability to sequence patient's genes, leading to more precise and effective medical treatments. The article raised questions that will be discussed at our upcoming forum, such as how to implement the proper use of genomic tests to select therapeutics, and how to pay for the genomic sequencing tests.
As part of this forum, we hope to go beyond these issues to address additional consequences of this genomic revolution, such as regulatory and reimbursement policies. Experts from the government, pharmaceutical and insurance industries, public health sector, and the cancer research community will participate in dynamic lectures and discussions to consider the complexities of integrating genetic testing into cancer care. Please plan on attending this free forum and help Ohio to get a head start on addressing the complex issues associated with these developments that may transform how we diagnose and treat cancer.
CASE CCC IN THE NEWS
Supplements Don't Help With Prostate Cancer
Health24.com - Apr 29, 2013
Dr. Eric Klein, chair of the Glickman Urological and Kidney Institute at the Cleveland Clinic in Ohio, said the new review's findings are consistent with past research.
Nurses Study Patients' Critical Connections During Phase 1 Clinical Trials: Clues to Cancer
Plain Dealer - Apr 29, 2013
Whether patients are on a clinical trial for a few weeks or a few months, the relationships they forge with the people who care for them are often intense. It's part of what Dr. Stanton Gerson, director of University Hospitals Seidman Cancer Center, calls a "high hover index."
Margene Manning Must Decide if Signing on for Phase 1 Clinical Trials is Worth Sacrifice: Clues to Cancer
Plain Dealer - Apr 29, 2013
Cancer patients who agree to take part in Phase 1 trials — early studies of experimental drugs and therapies to gauge their safety in humans — are a special breed, says Dr. Afshin Dowlati, director of the Developmental Therapeutics Program at Case Comprehensive Cancer Center since 2007...Manning's oncologist referred her to Dr. Neal Meropol, chief of the division of hematology/oncology at UH and associate director for clinical programs at UH Seidman. Meropol told Manning that it might be time to start thinking about a clinical trial...
Scared but Resolute, Vince Petro Enters the Unknown of Phase 1 Clinical Trial: Clues to Cancer
Plain Dealer - Apr 28, 2013
"The most innovative and cutting-edge concepts are being tested in Phase 1," says Dr. Neal Meropol, chief of the division of hematology/oncology at UH and CWRU Medical School, and associate director for clinical research...One week after Petro learned how serious his brain cancer was, and one day before his 59th birthday, he returned to UH to have the sutures removed and meet with Dr. Mitchell Machtay, chairman of radiation oncology at UH Case Medical Center and CWRU School of Medicine, and UH neuro-oncologist Dr. Lisa Rogers.
Vince Petro Gets Some Encouraging News, Keeps his Focus Forward: Clues to Cancer
Plain Dealer - Apr 28, 2013
"How are we doing here?" Dr. Hillard Lazarus asked Petro right before injecting him with the biopsy needle...In September, Petro once again traveled from his home in Ashtabula to see radiologist Dr. Mitchell Machtay...
God and Doctor
New York Times (blog) - Apr 25, 2013
Blog entry by Dr. Mikkael Sekeres...When he came to the hospital, he did not look well.
You might think that everyone with a recent leukemia diagnosis appears ill, but that isn't true. Some go to their primary care doctor with vague complaints of feeling tired or of having a cold, and a few hours after having their blood drawn are stunned to receive a phone call that they must get to the hospital immediately. Some get "stuck" in the Kübler-Ross stage of denial, refusing to believe they have leukemia even after they've received chemotherapy for it, or in the bargaining stage, negotiating for just one more bone marrow biopsy to confirm the diagnosis...
Prostate Cancer Risk Doubles in Patients with Lynch Syndrome
Helio/HemOnc Today - Apr 24, 2013
Perspective by Dr. Jorge Garcia...Prostate cancer remains the most common malignancy in men in North America. Despite major technical and therapeutic advances observed during the past decade – such as chemoprevention and early diagnosis...
Vitamin E Can Protect Against Liver Disease Associated With Obesity
Nature World News - Apr 24, 2013
Researchers found the role of vitamin E on liver in a group of obese mice by accident. Danny Manor, an associate professor at the Case Western Reserve University School of Medicine, said that the team was actually practicing surgical techniques on liver tissue while they were investigating the effect of vitamin E deficiency in the central nervous system of mice.
MARK YOUR CALENDARS
Race for the Place- Join Our Team!
The Race for the Place, an event that benefits the Gathering Place, will be held Sunday, June 2 at Beachwood Place Mall. The Case CCC has created a team. Click here to join the team or to show your support by making a donation. Contact Gillian Todd for more information.
Annual Scientific Retreat
The Annual Cancer Center Scientific Retreat will commence the evening of Thursday, July 11 with a speaker and reception in the Wolstein Research Building Auditorium. The Retreat will continue the next day, Friday, July 12, at Corporate College East. The agenda is still be finalized. Details will be circulated soon!
SPORE Supplement: Call for Projects
The NCI has announced an opportunity for SPOREs to apply for funding for a two-year supplemental project, at $150K per year direct costs, that is directed at the study of microbial pathogens and cancers. Dr. Sanford Markowitz, PI of the Case GI Cancer SPORE, has asked that any investigators with project ideas that fit the above description and are focused on GI cancer send a short email to firstname.lastname@example.org.
Computational Genomic Epidemiology of Cancer Postdoctoral Training Program
The Case CCC invites applications to its 2-3 year NCI-funded Computational Genomic Epidemiology of Cancer Postdoctoral Training Program. The program combines a mentored cancer research project designed by the fellow in collaboration with their mentors with a specialized curriculum of formal didactic training and individualized longitudinal curriculum.
This program is designed to prepare trainees for careers as independent investigators engaged in research at the intersection of cancer research, genetics, epidemiology, biostatistics and computer science. Cancer researchers obtaining training will have the skills vital to decipher the complex pathways comprising genetic and environmental risk factors for disease, and will ultimately be able to provide clinicians and their patients with valuable information for the prevention and treatment of cancer.
Candidates with an MD, PhD, or MD/PhD degree, strong quantitative skills, and an interest in a career in genetics research are encouraged to apply.
2013 Health Care Hero Awards
Congratulations to the following Cancer Center members were recognized by Crain's Cleveland Business as 2013 Health Care Heroes:
- Physician Category, research: Dr. Michael Lederman
- Advancements in Healthcare Category, individual: Dr. Goutham Narla
Recipients will be honored at a luncheon later this May.
NSG Gamma Mice Available for Purchase
The Athymic Animal & Xenograft Core Facility has a large number of NSG gamma mice available for purchase. The mice are a variety of weights and ages, up to 12 weeks of age. If interested, please contact Pamela Steel at email@example.com and provide PI name, phone number, protocol number, and speedtype.